Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,627 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,473
Recruiting: 1,285
Ph III recruiting: 130
Growth YoY: +6.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,641)

clinicaltrialsPublishedShowing 151–200 of 712 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07485647	Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing	recruiting	Phase 2	50	Eden BiltiboOTHER	1	Aug 19, 2026	clinicaltrials
NCT06376526	IMMUNOPLANT for Newly Diagnosed Multiple Myeloma(IMMUNOPLANT)	recruiting	Phase 2	150	Dickran Kazandjian, MDOTHER	1	Aug 18, 2026	clinicaltrials